CD44 and ductal breast carcinoma in situ: Breast cancer stem-like cells (BCSCs) exhibiting a CD44+/CD24-/lin- phenotype as well as the expression and activity of aldehyde dehydrogenase 1 (ALDH1) are detected in DCIS [7,8].